Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study).

[1]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[2]  D. Corrado,et al.  Screening for hypertrophic cardiomyopathy in a young male military population. , 2003, The American journal of cardiology.

[3]  B. Maron,et al.  Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[4]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[5]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[6]  B. Maron,et al.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.

[7]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[8]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[9]  B. Howard,et al.  Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. , 1999, Circulation.

[10]  B. Maron,et al.  Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. , 1999, Journal of the American College of Cardiology.

[11]  P. Elliott,et al.  Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[12]  B. Maron,et al.  Comparison of phenotypic expression of hypertrophic cardiomyopathy in patients from the United States and Germany. , 1999, The American journal of cardiology.

[13]  F. Triposkiadis,et al.  Hypertrophic cardiomyopathy in Greece: clinical course and outcome. , 1998, Chest.

[14]  Asso,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[15]  B. Howard,et al.  Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. , 1997, Circulation.

[16]  B. Howard,et al.  Major electrocardiographic abnormalities among American Indians aged 45 to 74 years (the Strong Heart Study). , 1996, The American journal of cardiology.

[17]  D. Atkins,et al.  Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. , 1996, Circulation.

[18]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[19]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[20]  B. Howard,et al.  Cardiovascular disease risk factors among American Indians. The Strong Heart Study. , 1995, American journal of epidemiology.

[21]  P. Savage,et al.  Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. , 1995, American journal of epidemiology.

[22]  B. Maron,et al.  Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. , 1994, The American journal of cardiology.

[23]  P. Savage,et al.  The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. , 1990, American journal of epidemiology.

[24]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[25]  W. Williams,et al.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[26]  J. Ware,et al.  Echocardiographic Measurements in Normal Subjects from Infancy to Old Age , 1980, Circulation.

[27]  B. Gilbert,et al.  Hypertrophic cardiomyopathy: subclassification by m mode echocardiography. , 1980, The American journal of cardiology.

[28]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[29]  R. Hui,et al.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. , 2004, The American journal of medicine.

[30]  T. Sakamoto,et al.  Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening. , 1987 .